HOME >> MEDICINE >> NEWS
Vitamin C depletion correlates with lower body fat, not weight loss during short-term diet

Too little vitamin C in the blood stream has been found to correlate with increased body fat and waist measurements. Nutrition researchers from Arizona State University report that the amount of vitamin C in the blood stream is directly related to fat oxidation the body's ability to use fat as a fuel source during both exercise and at rest.

Bonnie Beezhold, a graduate student in the laboratory of Dr. Carol Johnston, presented the most recent study, on the impact of vitamin C depletion on a short-term diet, on April 3 at Experimental Biology 2006 in San Francisco. The presentation was part of the scientific program of the American Society for Nutrition, Inc. (ASN).

Before beginning a controlled four-week, low-fat diet, 20 obese men and women were randomized by gender and body weight into either a Vitamin C group, taking a 500 mg vitamin C capsule daily, or a control group, taking a capsule, identical in appearance to the vitamin, containing a placebo. Neither participants nor researchers knew who was receiving which capsule until the study was over. All participants consumed a low-fat diet that the researchers adjusted individually to promote slow weight loss (about two pounds per week). The diet contained 67 percent of the USRDA (recommended daily allowance) for vitamin C (40 mg/d).

At the beginning of the clinical trial, participants with the lowest concentrations of vitamin C in their blood had the highest body fat mass and tended not to oxidize fat well compared to their less obese counterparts. As the participants moved through the four week diet, with a steady amount of vitamin C being consumed, blood vitamin C concentrations increased 30 percent in those taking vitamins and fell 27 percent in the control group whose only vitamin C intake was the 67 percent of the USRDA contained in the food. As vitamin C blood concentrations fell, so did the participants' ability to oxidize fat (an 11 percent reduction).

The highly-contr
'"/>

Contact: Sarah Goodwin
415-905-1015
Federation of American Societies for Experimental Biology
3-Apr-2006


Page: 1 2

Related medicine news :

1. Vitamin D supplements may offer cheap and effective immune system boost against TB
2. Vitamin D supplements should be given to Asian children for two years from birth
3. Vitamin A deficiency linked to major intestinal surgery
4. Vitamin D and calcium supplements have varied effects on breast cancer risk
5. Vitamin D targets thrombosis in cancer patients
6. Vitamin C and E supplements do not prevent pre-eclampsia in pregnant women at risk
7. Vitamin D inhibits progression of some prostate cancers
8. Vitamin D signals to prevent bone loss during osteoporosis
9. Vitamin D supplementation during pregnancy could reduce osteoporosis in children
10. Vitamin D can play role in lung health
11. Vitamin D status appears more important than high calcium intake for maintaining calcium metabolism

Post Your Comments:
(Date:10/22/2014)... October 22, 2014 Lintelus, Inc., an ... Vice President of Sales, will be speaking on the ... Technology Expo on October 28, at the Holiday Inn ... a booth as well as a Tech Demo at ... can create a more engaging event experience. , The ...
(Date:10/22/2014)... October 22, 2014 Akeso Biomedical, ... for the treatment of bacterial infections, microbial biofilms, and ... joined its board of directors. , Dr. ... Systems at The Massachusetts Institute of Technology, or MIT. ... since 1968. Dr. Sinskey also holds positions as Co-Director ...
(Date:10/22/2014)... Maureen Salamon HealthDay Reporter ... undergoing in vitro fertilization (IVF) are only about half as ... assisted reproduction technique, new research indicates, and the racial disparity ... study, about 31 percent of white patients became pregnant after ... Analyzing more than 4,000 IVF cycles over two years to ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, 2014 (HealthDay ... to increased blood pressure, according to a new study. ... pressure for young adult women or for teenagers, according to ... or moderately, their risk of high blood pressure was cut ... in older adult men and women," said lead researcher Dr. ...
(Date:10/22/2014)... Measures taken by Firestone officials at the company,s ... the spread of the disease there and could prove ... Co. provides health services to about 80,000 employees, retirees, ... Between Aug. 1 and Sept. 23, there were ... people. That incidence rate of 0.09 percent was much ...
Breaking Medicine News(10 mins):Health News:Jay Cormier, Sr. Vice President of Sales for Lintelus, Speaks about Event Technology Integration at Meetings Technology Expo in NYC 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 4Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2
(Date:10/22/2014)... JOLLA, Calif. , Oct. 22, 2014 ... RGLS ), a biopharmaceutical company leading the ... microRNAs, today announced that it has demonstrated ... an ongoing clinical study evaluating RG-101, a ... the treatment of hepatitis C virus infection ...
(Date:10/20/2014)... , 20 de octubre de 2014  PneumRx, ... campo de la pulmonología intervencional, anunció hoy la ... casi 3 meses antes de lo programado. El Estudio ... de dispositivo de investigación (IDE) aprobada por la ... sistema de espiral de reducción de volumen pulmonar ...
(Date:10/20/2014)... 20, 2014  ResMed (NYSE: RMD ... Data Exchange program, a comprehensive suite of software ... and other health care providers. ... critical patient information. It integrates valuable sleep and ... patient management platforms with customers, in-house or third-party ...
Breaking Medicine Technology:A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 3A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 4A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 5A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 6A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 7A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 8PneumRx concluye inscripción en prueba fundamental RENEW 2PneumRx concluye inscripción en prueba fundamental RENEW 3ResMed Launches ResMed Data Exchange 2
Cached News: